Clinical Trials Directory

Trials / Conditions / Unresectable Gallbladder Cancer

Unresectable Gallbladder Cancer

19 registered clinical trials studyying Unresectable Gallbladder Cancer — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer
NCT05919095
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2
RecruitingA Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unrese
NCT06423170
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2
TerminatedVeliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Ur
NCT01282333
National Cancer Institute (NCI)Phase 1
TerminatedCediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
NCT01229111
National Cancer Institute (NCI)Phase 2
CompletedEverolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refra
NCT00949949
Mayo ClinicPhase 1
TerminatedTrastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer Th
NCT00478140
National Cancer Institute (NCI)Phase 2
CompletedErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Nec
NCT00397384
National Cancer Institute (NCI)Phase 1
CompletedBevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors
NCT00356889
National Cancer Institute (NCI)Phase 2
CompletedS0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
NCT00238212
National Cancer Institute (NCI)Phase 2
CompletedLapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer
NCT00107536
National Cancer Institute (NCI)Phase 2
CompletedLapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot B
NCT00101036
National Cancer Institute (NCI)Phase 2
TerminatedEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
NCT00087191
National Cancer Institute (NCI)N/A
TerminatedBortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Du
NCT00085410
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
NCT00033462
National Cancer Institute (NCI)Phase 2
Completed7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid
NCT00031681
National Cancer Institute (NCI)Phase 1
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
National Cancer Institute (NCI)Phase 1
TerminatedBMS-247550 in Treating Patients With Liver or Gallbladder Cancer
NCT00023946
National Cancer Institute (NCI)Phase 2
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1
WithdrawnStent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating
NCT00253617
Jonsson Comprehensive Cancer CenterPhase 3